Nobuko Hijiya
Section Head of Oncology, Division of Hematology, Oncology, and Stem Cell Transplant · Columbia Univ Coll of Phys & Surgeons
Credentials: · · · ·
History
PresentDivision of Hematology, Oncology, and Stem Cell Transplant Section · Columbia Univ Coll of Phys & Surgeons
New York University Medical Center
Research
Immunity · 1996 · 581 citations
In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides
Proceedings of the National Academy of Sciences of the United States of America · 1992 · 241 citations
The Journal of Pathology · 2008 · 235 citations
11 papers
11 papers
- JR
10 papers
- JS
10 papers
9 papers
9 papers
9 papers
9 papers
Grants
- 2023–2028
Clinical Trials Specialist in Developmental Therapeutics
National Cancer Institute · R50
Contact PI · $703.8K · Columbia University Health Sciences
Clinical trials
- 2014
Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
Study chair · Terminated · Phase 1
Therapeutic Advances in Childhood Leukemia Consortium
- 2009–2011
T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)
Study chair · Terminated · Phase 2
Therapeutic Advances in Childhood Leukemia Consortium
- 2026–2033
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
- 2025–2029
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Site PI · Recruiting · Phase 3
Children's Oncology Group